Review Article
Prevalence and Epidemiology of Diabetes Mellitus Type 3C
- Samreen Riaz *
University of the Punjab, Lahore, Pakistan.
*Corresponding Author: Samreen Riaz, University of the Punjab, Lahore, Pakistan.
Citation: Riaz S. (2025). Prevalence and Epidemiology of Diabetes Mellitus Type 3C, International Journal of Biomedical and Clinical Research, BioRes Scientia Publishers. 3(3):1-10. DOI: 10.59657/2997-6103.brs.25.052
Copyright: © 2025 Samreen Riaz, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: January 09, 2025 | Accepted: January 31, 2025 | Published: February 07, 2025
Abstract
Type-II diabetes mellitus is a particularly heterogeneous and multifactorial metabolic disorder that is characterized by a combination of insulin insufficiency and insulin resistance. The prevalence of diabetes mellitus has risen exponentially over the last three decades, with resultant increase in morbidity and mortality mainly due to its complications. There is need of Increases awareness of these complications among patients and populations, this facilitates early detection and prevention of these diseases. The earlier diagnosis, timely appropriate treatment may help in avoiding severe, irreversible disability and deformity, which can be done with the tool of patient education and conducting seminar to increase awareness.
Keywords: diabetes mellitus; high blood glucose levels; pancreatitis
Introduction
Diabetes mellitus is one of the most prevalent metabolic disorders in the world, it is characterized by the high blood glucose levels (Hyperglycemia) due to the defects in the action of insulin, secretion of insulin or may be due to both of them [1]. Type I and Type II diabetes are considered as the major types of the diabetes to be known by that time and type II Diabetes is more prevalent (>85%) then that of the type I [2]. Type I Diabetes is considered to be caused by the deficit insulin secretion from the beta cells of pancreas that actually happens due to the autoimmune devastation of the beta cells. On the other hand, diabetes type II is caused by the two coupled reasons, first one is the resistance to insulin action and second one is the insufficient compensatory insulin secretory response. “Gestational Diabetes mellitus” (GDM), that is also a situation of glucose intolerance, is known to be recognized during the pregnancy. Except of these above-mentioned types of Diabetes, there are some more specific categories of the diabetes mellitus and the Type 3c Diabetes fall in this category [3-5].
Among the people who are suffering from the Diabetes mellitus, approximately 2 percent of them have the type 3c diabetes [6-10]. Type 3c diabetes might happen due to genetic as well as the non-genetic factors that comprises pancreatic removal, pancreatitis, pancreatic ductal adenocarcinoma, hemochromatosis or cystic fibrosis. One of the most dominating causes of the Type 3c diabetes is chronic pancreatitis. Unfortunately, patients suffering from the type 3c diabetes are not diagnosed properly and timely that is one of the main causes of delay in their required treatment [11-15].
Type 3c Diabetes Mellitus (T3cDM)
Type 3c diabetes mellitus has been designated as the secondary diabetes and usually called as the pancreatogenic diabetes. One can also develop type 3c if he/she has a part or all of the pancreas removed because of any other damage. Some people who take steroids can also develop this type of diabetes. This is also called as steroid-induced diabetes, and is more common in the group of people which are at high risk of type II diabetes.
Table 1A: Sex and age distribution across groups.
Epidemiology | |||||||||
Groups | n | % | Male | Female | Male % | Female % | Age (Average/y) | Age (SEM/y) | |
AP | 983 | 74.80% | 525 | 458 | 53.40% | 46.60% | 56.7 | 0.55 | |
RAP-2 | 2nd AP | 173 | 13.20% | 111 | 62 | 64.20% | 35.80% | 52.6 | 1.21 |
RAP-3 | 3rd AP | 43 | 3.30% | 25 | 18 | 58.10% | 41.90% | 51.9 | 2.25 |
RAP-4 | 4th AP | 24 | 1.80% | 16 | 8 | 66.70% | 33.30% | 50.7 | 3.59 |
RAP-5+ | 5th AP | 30 | 2.30% | 23 | 7 | 76.70% | 23.30% | 52.57 | 3.56 |
RAP | 270 | 20.50% | 175 | 95 | 64.80% | 35.20% | 52.7 | 0.93 | |
CP | 62 | 4.70% | 45 | 17 | 72.6%* | 27.40% | 55.5 | 1.84 | |
Total | 1315 | 100.00% | 745 | 570 |
*p lessthan 0.05 when comparing AP and CP; p lessthan 0.05, AP: Acute Pancreatitis, RAP: Recurrent Acute Pancreatitis, CP: Chronic Pancreatitis, n: number, SEM: Standard Error of the Mean, y: Years
Table 1B: Etiology os acute pancreatitis across study cohorts.
Leading Etiology | ||||||
Groups | AP | RAP | CP | |||
n | % | n | % | n | % | |
Biliary | 493 | 50.2% | 63 | 20.7% | 7 | 11.3%* |
Alcohol | 191 | 19.4% | 119 | 39.1% | 32 | 51.6%* |
Lipid | 48 | 4.9% | 29 | 9.5% | 1 | 1.6% |
Idiopathic | 189 | 19.6% | 72 | 23.8% | 18 | 29.0% |
*p lessthan 0.05 when comparing AP and CP.
Table 1C: Etiology of recurrent acute pancreatitis.
Leading Aetiology | ||||||||
Groups | RAP-2 (n=173) | RAP-3 (n=43) | RAP-4 (n=24) | RAP-5+ (n=30) | ||||
n | % | n | % | n | % | n | % | |
Biliary | 43 | 24.9% | 4 | 9.3%b | 2 | 8.3%° | 6 | 20% |
Alcohol | 65 | 37.6% | 21 | 48.8%b | 9 | 37.5% | 12 | 40.0% |
Lipid | 17 | 9.8% | 1 | 2.3% | 3 | 12.5% | 3 | 10.0% |
Idiopathic | 41 | 23.7% | 12 | 27.9% | 6 | 25.0% | 5 | 16.7% |
a: p lessthan 0.05 when comparing AP and RAP2. b: p lessthan 0.05 when comparing AP and RAP3. c: p lessthan 0.05 when comparing AP and RAP4. d: p lessthan 0.05 when comparing AP and RAP5+.
Table 2: Clinical Characteristics for Common Forms of Diabetes.
T1DM | T2DM | T3cDM | |||
Associated With | Autoimmunity | Obesity | Chronic Pancreatitis | Cystic Fibrosis | Pancreatic Resection |
Median Age of Onset | 2nd decade of life | 6th decade of life | 5th decade of life | 3rd decade of life | Within 5 yrs. of surgery |
Pancreatic Insufficiency | No | No | Yes | Yes | Yes |
Hepatic Insulin Sensitivity | Normal or decreased | Decreased | Normal or decreased | ? | Normal or decreased |
Peripheral Insulin Sensitivity | Normal or decreased | Decreased | Normal | ? | Normal |
Diabetic Ketoacidosis | Yes | No | No | No | No |
Hypoglycemia Risk | Increased | Normal | Normal or increased | Normal or increased | Normal or increased |
Pancreatic Polypeptide Response | Normal or decreased | Normal or increased | Decreased or Absent | Absent | Absent |
Pathogenesis of Type 3c Diabetes mellitus
The pathogenesis of T3cDM is characterized by the declination in the insulin production that might be due to the reduced number of the islet’s cells or due to the loss of functionality that is attributed to the fibrosis or sclerosis [16-20]. Basically, the damage of the pancreatic tissue causes the deficiency of insulin and its mechanism can be explained by the functionality dependent interplay between the acinar cells and islets cells.
Pancreatic Function
Pancreas holds two significant functions in the human body, firstly, it controls the blood glucose levels and secondly, it assists in the digestion of the food. Anatomically, pancreas is divided into the five regions, it is associated with the gall bladder, duodenum and spleen. It has both the exocrine and the endocrine regions but the maximum region of the pancreas owns exocrine function that is responsible for the formation and release of the digestive enzymes into the duodenum. Acinar cells that make up to 85 percent of the pancreatic cells are devoted for synthesizing the enzymes for carbohydrates, lipids and protein digestion. The main enzyme contributors include amylases, lipases and trypsin and zymogens (proelastase, trypsinogen, chymotrypsinogen procarboxypeptidase). Endocrine secretory tissues residing in the pancreas are called as the islets of langerhans, containing four types of the cells, out of them beta cells (Insulin secreting cells) are in the huge amount. In Type I and Type II Diabetes mellitus, deficient insulin production leads to the hyperglycemia but the digestion of food is unaffected. On the other hand, in Type 3c Diabetes mellitus, digestion of food also gets effected.
Causes of Type3c Diabetes Mellitus
One of the most frequently recognized causes of the Type 3c diabetes mellitus is chronic pancreatitis. The most commonly identified cause of type 3c diabetes is chronic pancreatitis. According to a single-center review, causes of the type 3c diabetes were recorded as: “chronic pancreatitis” (79%), “pancreatic ductal adenocarcinoma” (8%), “haemochromatosis” (7%), “cystic fibrosis” (4%), and previous pancreatectomy (2%), results are also depicted in the Pie Chart [21-25].
Chronic Pancreatitis and Type 3c Diabetes mellitus
Progressive inflammation in the pancreatic tissue results in the chronic pancreatitis. Genetic and environmental factors both are considered as its cause. It is characterized by the gradual devastation of the pancreatic secretory parenchyma and results in the replacement with the fibrous cells. This condition leads to the Diabetes mellitus [87]. Pancreatitis starts as the pancreatitis and cause the inflammation. On the other hand, reactive oxygen species (ROS) are the triggering factors for the pancreatitis, they are the enhancers of inflammation that have the potential to convert the impaired acinar cell into a manufactory for the cytokines and chemokines [26]. Such type of the inflammatory responses are the instigating factors for the beta cell disruption and resultantly, low levels of insulin and hyperglycemic condition [27-30]. However, there is lack of systematic studies that are capable of examining the main genetic differences between type 3c diabetes secondary to chronic pancreatitis.
Pancreatic Ductal Adenocarcinoma and Type 3c Diabetes Mellitus
Pancreatic cancer is the leading cause of wide scale deaths around the world and its risk is high in the patients with the new-onset diabetes. Therefore, it is named as pancreatic ductal adenocarcinoma (PDAC)-associated diabetes mellitus (PDAC-DM), a “type 3C diabetes”. The onset of “PDAC-DM” mostly occurs 2–5 years prior to the diagnosis of “PDAC” that’s why its early diagnosis is very significant. However, it is not possible to differentiate PDAC-DM from the other diabetes on the basis of clinical signs and symptoms so, there is the urgent need of the specific markers in the health sector [31-35].
Cystic Fibrosis and Type3c Diabetes Mellitus
Cystic fibrosis diabetes is the most apparent form of diabetes in people with cystic fibrosis. Although it possesses characteristics of both type 1 and type 2, but it is a quite different condition. Type 3c diabetes develops mainly due to the damage of pancreas that can happen because of a few typical reasons. Although it is much different from other types, still you can get a wrong diagnosis of diabetes type 2 because Type 3c isn’t well diagnosed. Becoming unable to get the right diagnosis can be really hard to deal with it emotionally. You may feel angry for not having the right treatment or maybe you could just get ruined by the whole process. Thus, make sure you find the right person to communicate with.
Clinical Presentation of Type 3c Diabetes Mellitus
Large no of patients suffering from the type 3c Diabetes mellitus have some history of pancreatitis along with abdominal pain, steatorrhea or maldigestion with nutritional deficiencies and glucose intolerance. Patients may also flex the symptoms of maldigestion or abdominal pain without any diagnosis of chronic pancreatitis, or even may be asymptomatic except for glucose intolerance, and only through careful clinical evaluation is pancreatic disease suspected [36-40].
Symptoms of Diabetes Type 3c
Diabetes type 3c is a complex situation in which this is very difficult to diagnose that actually what the problem is. In specific, there are a number of symptoms that are associated with PEI (Pancreatic exocrine insufficiency). In this disease, the pancreas is not functional anymore and it does not provide the body with essential enzyme required for appropriate digestion. This is mainly due to chronic pancreatitis and cystic fibrosis. That is the reason why the symptoms of Diabetes type 3c are usually linked with digestive tract symptoms. The major symptoms include [41]:
- Diarrhea
- Abdominal bloating
- Eating issues
- Bloating and abdominal pain
- Nausea
- General fatigue
These symptoms are usually accompanied by a number of conditions like the patients with a history pancreatic disorder, an instance of weight loss and a severe pain [42-45].
Diagnosis of Diabetes Type 3c
Diagnosis of Diabetes type 3c is too complicated and that’s why it renders it undiagnosed and maltreated in most of the cases. A few reasons of its being difficult to diagnose is high variability of glucose level in the blood i.e., it sometimes becomes too high and sometimes become too low. That's why it sometimes sounds like Diabetes type 1 and hyperglycemia and sometimes it seems to be hyperglycemic. Now, after a long run of research there has been set a few standard steps to follow when diagnosing for Diabetes [46] which are:
- Check for pancreatic exocrine insufficiency.
- Perform pathological pancreatic imaging.
- Check for Diabetes type 1-associated auto-antibodies.
Based on these criteria there can be a number of ways to check for type 3c and rule out the other types, for example absence of pancreatic enzymes in body after a glucose or mixed meal can be a true sign of type 3c. [47] HbA1C was initially thought to be a screening test for DM type 3c but there is a much lower connection between A1c and insulin tolerance levels, that’s why HbA1c can’t be used as a standard technique to diagnose DM type 3c [48]. It is simply conclusive that, the major relation of diabetes type 3c is with PEI and pancreatic disorders, so diagnosing in depth for the problems of associated with pancreatic problems is the major gateway to diagnose type 3c [74].
General Overview of The Differential Criteria Between T2 and T3c DM
Type 3c is characterized by deficiency of PP (pancreatic polypeptide) whereas type 2 contains high levels of nutrient stimulated pancreatic polypeptide i.e., PP. There are different criteria on which Type 2 DM and Type 3c DM can be categorized, which includes the pathological imagining i.e., endoscopy, MRI and ultrasound etc. Absence of some autoimmune markers associated with Type 1 DM is another basis of differentiation between these two. Some minor criteria include the identification of B-cell functionality, IR (Insulin Resistance), Abnormalities of incretin secretion and low levels of fat-soluble vitamins (A, D, E, K). However, Type 3c and Type 2 DM still overlaps at many points, which will need more research work to further differentiate the different types of diabetes [49-55].
Management of Diabetes Type 3c
Management of Diabetes type 3c is not a much-researched field due to less reported and diagnosed cases [56]. Management is based upon the cause of particular type 3c diabetes. Usually, it is suggested for the patients to get some knowledge and awareness about the diabetes management in sessions about the diabetes awareness programs and seminars [57-60]. Primarily the basic need is to maintain a little greater than the normal level of glucose in body i.e., to avoid hypoglycemia [78]. On the other hand, it is suggested for the patients with a history of chronic pancreatitis to take a diet that is rich in dietary fiber and lacks fat. In this way they can avoid the symptoms of steatorrhea, and they must also need to prevent hyperglycemia through diet [61]. Thus, it can be said that the only way to manage this least researched form of diabetes is to use a multi-dimensional approach in which both nutritional and therapeutic parameters are taken under use [62]. And to minimize the serious complications, strategic management should be balanced to maintain the maximum glycemic control. Other healthy improvisions can also be helpful to prevent hyperglycemia [63-70].
Treatment of Diabetes Type 3c
About 75% of the type 3c diabetes result from the chronic pancreatitis which ultimately increases the risk of development of carcinoma in the pancreas. Treatment with insulin or insulin secretagogue can readily increase the risk of malignancy due to their hypoglycemic activity, whereas metformin could be beneficial in reducing it. However, in advanced type 3c DM insulin replacement therapy is preferred, which helps the patients achieve optimal glucose concentration in blood by mimicking the physiological delivery of insulin in a very comprehensive approach [71-81].
Conclusion
Diabetes mellitus is a particularly heterogeneous and multifactorial metabolic disorder that is characterized by a combination of insulin insufficiency and insulin resistance. The prevalence of diabetes mellitus has risen exponentially over the last three decades, with resultant increase in morbidity and mortality mainly due to its complications. There is need of Increases awareness of these complications among patients and populations, this facilitates early detection and prevention of these diseases. The earlier diagnosis, timely appropriate treatment may help in avoiding severe, irreversible disability and deformity, which can be done with the tool of patient education and conducting seminar to increase awareness.
References
- Suhail, M., Riaz, S. (2020). In Silico Proteomics EVOO Therapy for Lipid Lowering in the Patients of Diabetes Mellitus. In Biochemical Testing-Clinical Correlation and Diagnosis. IntechOpen.
Publisher | Google Scholor - Johnson, C. D., Arbuckle, R., Bonner, N., Connett, G., Dominguez-Munoz, E., et al. (2017). Qualitative Assessment of The Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) To Inform the Development of a Patient-Reported Outcome (PRO) Instrument. The Patient-Patient-Centered Outcomes Research, 10:615-628.
Publisher | Google Scholor - Conlon, K. C., Duggan, S. N. (2017). Pancreatogenic Type 3c Diabetes: Underestimated, Underappreciated and Poorly Managed. Practical Gastroenterol, 15.
Publisher | Google Scholor - Ewald, N., Kaufmann, C., Raspe, A., Kloer, H. U., Bretzel, R. G., et al. (2012). Prevalence of Diabetes Mellitus Secondary to Pancreatic Diseases (Type 3c). Diabetes/Metabolism Research and Reviews, 28(4):338-342.
Publisher | Google Scholor - Ewald, N., Kaufmann, C., Raspe, A., Kloer, H. U., Bretzel, R. G., et al. (2007). Prevalence of Diabetes Mellitus Secondary to Pancreatic Diseases (Type 3c). Experimental and Clinical Endocrinology & Diabetes, 115(S 1):P01_028.
Publisher | Google Scholor - Moran, A., Brunzell, C., Cohen, R. C., Katz, M., Marshall, B. C., et al. (2010). Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A Position Statement of The American Diabetes Association and A Clinical Practice Guideline of The Cystic Fibrosis Foundation, Endorsed by The Pediatric Endocrine Society. Diabetes Care, 33(12):2697-2708.
Publisher | Google Scholor - Rickels, M. R., Bellin, M., Toledo, F. G., Robertson, R. P., Andersen, D. K., et al. (2013). Detection, Evaluation and Treatment of Diabetes Mellitus in Chronic Pancreatitis: Recommendations from Pancreas Fest 2012. Pancreatology, 13(4):336-342.
Publisher | Google Scholor - Makuc, J. (2016). Management of Pancreatogenic Diabetes: Challenges and Solutions. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 311-315.
Publisher | Google Scholor - Andersen, D. K., Andren-Sandberg, Å., Duell, E. J., Goggins, M., Korc, M., et al. (2013). Pancreatitis-Diabetes-Pancreatic Cancer: Summary of an NIDDK-NCI Workshop. Pancreas, 42(8):1227-1237.
Publisher | Google Scholor - Golden, S. H., Robinson, K. A., Saldanha, I., Anton, B., Ladenson, P. W. (2009). Prevalence and Incidence of Endocrine and Metabolic Disorders in The United States: A Comprehensive Review. The Journal of Clinical Endocrinology & Metabolism, 94(6):1853-1878.
Publisher | Google Scholor - Forouhi, N. G., Wareham, N. J. (2010). Epidemiology of Diabetes. Medicine, 38(11):602-606.
Publisher | Google Scholor - American Diabetes Association. (2005). Diagnosis and classification of diabetes mellitus. Diabetes Care. 28(Suppl 1):S37-4S2.
Publisher | Google Scholor - Liu, Q. C., Zhuang, Z. H., Zeng, K., Cheng, Z. J., Gao, F., et al. (2009). Prevalence of Pancreatic Diabetes in Patients Carrying Mutations or Polymorphisms of The PRSS1 Gene in The Han Population. Diabetes Technology & Therapeutics, 11(12):799-804.
Publisher | Google Scholor - Hart, P. A., Bellin, M. D., Andersen, D. K., Bradley, D., Cruz-Monserrate, Z., et al. (2016). Type 3c (Pancreatogenic) Diabetes Mellitus Secondary to Chronic Pancreatitis and Pancreatic Cancer. The lancet Gastroenterology & Hepatology, 1(3):226-237.
Publisher | Google Scholor - Domschke, S., Stock, K. P., Pichl, J., Schneider, M. U., Domschke, W. (1985). Beta-Cell Reserve Capacity in Chronic Pancreatitis. Hepato-Gastroenterology, 32(1):27-30.
Publisher | Google Scholor - Ewald, N., Kaufmann, C., Raspe, A., Kloer, H. U., Bretzel, R. G., et al. (2012). Prevalence of Diabetes Mellitus Secondary to Pancreatic Diseases (Type 3c). Diabetes/Metabolism Research and Reviews, 28(4):338-342.
Publisher | Google Scholor - Sarles, H. (1986). Etiopathogenesis and Definition of Chronic Pancreatitis. Digestive Diseases and Sciences, 31(9):91-107.
Publisher | Google Scholor - Braganza, J. M., Lee, S. H., McCloy, R. F., McMahon, M. J. (2011). Chronic Pancreatitis. The Lancet, 377(9772):1184-1197.
Publisher | Google Scholor - Sasikala, M., Talukdar, R., Radhika, G., Rao, G. V., Pradeep, R., et al. (2012). β-Cell Dysfunction in Chronic Pancreatitis. Digestive Diseases and Sciences, 57(7):1764-1772.
Publisher | Google Scholor - Gao, W., Zhou, Y., Li, Q., Zhou, Q., Tan, L., et al. (2015). Analysis of Global Gene Expression Profiles Suggests a Role of Acute Inflammation in Type 3C Diabetes Mellitus Caused by Pancreatic Ductal Adenocarcinoma. Diabetologia, 58(4):835-844.
Publisher | Google Scholor - Gudipaty, L., Rickels, M. R. (2015). Pancreatogenic (Type 3c) Diabetes. Pancreapedia: The Exocrine Pancreas Knowledge Base.
Publisher | Google Scholor - Riaz, S. And Mughal, M.S. (2000). Histopathological Changes in Kidney of Grass Carp, Ctenopharyngodon Idella as Manifested by Chromium Intoxication. Biologia, 46(1&2):83-88.
Publisher | Google Scholor - Riaz, S. And Mughal, M.S. (2002). Histopathological Changes in Spleen of Grass Carp, Ctenopharyngodon Idella as Manifested by Chromium Intoxication. Biologia, 48(1&2):401-405.
Publisher | Google Scholor - Riaz, S., Mughal, M.S. (2002). Effect of Different Levels of Tannery Wastes on Serum Enzymes of Quail Chicks Coturnix Japonica. Biologia, 2002. 48(1&2):389-400.
Publisher | Google Scholor - Riaz, S., Mughal, M.S. (2002). Histopathological Changes of Different Levels of Tannery Wastes Replaced by Chrome Shavings in Liver & Kidney of Quail Chicks Coturnix Japonica. Biologia, 48(1&2):341-349.
Publisher | Google Scholor - Riaz, S., Riaz, A. (2006). Effect of Different Levels of Chrome Shaving on Total Body Weight of Quail Chicks Coturnix Japonica. Journal of Biochemistry and Molecular Biology. 39(1&2):10-19.
Publisher | Google Scholor - Riaz, S., Shoukat S., Mughal, M.S. (2007). Fluoride Toxicity on The Histopathological Aspects of Liver in The Cirrhinus Mrigala. Journal of Biochemistry and Molecular Biology. 39(3):165-173.
Publisher | Google Scholor - Riaz, S., Shoukat S., Mughal, M.S. (2008). Fluoride Toxicity on The Histopathological Aspects of Kidney in The Cirrhinus Mrigala. Journal of Biochemistry and Molecular Biology. 40(3):20-24.
Publisher | Google Scholor - Riaz, S., Alam S.S., Rabbani N., Thornalley P.J., Aktar M.W. (2009). Proteomic Strategies to Study the Protein Biomarker for Diabetes Mellitus and Effect of Thiamine on Their Levels. Proceeding of Symposium of Genomics, Proteomics and Metabolomics. Modern Trends in Biotechnology. Dept. Of MMG, University of The Punjab, Lahore. 198-212.
Publisher | Google Scholor - Riaz, S., Alam, S.S., Ikram, A. (2006). Histopathological Changes Observed in The Heart and Gizzard of Quail Chicks Coturnix Japonica Administrated by The Different Levels of Chrome Shaving. African Journal of Biotechnology. 5(19):1765-1769.
Publisher | Google Scholor - Riaz, S., Alam, S.S. (2006). Evaluation of Nutritive Value of Different Levels of Chrome Shaving Partially Replacing Animal Protein in The Feed on The Performance of Quail Chicks. International Journal of Agricultural and Biological Science, 1(1):1-7.
Publisher | Google Scholor - Riaz, S., Alam, S.S., Ali, G. (2006). Effect of Different Levels of Chrome Shavings on Hematological Parameters in The Blood of Quail Chicks. International Journal of Agricultural and Biological Science, 1(1):27-32.
Publisher | Google Scholor - Naila Rabbani, Saadia Shahzad Alam, Samreen Riaz, James Larkin, M Waheed Akhtar, et aly. (2009). High Dose Thiamine Therapy for People with Type 2 Diabetes and Microalbuminuria: A Randomised, Double-Blind, Placebo-Controlled Study. Diabetologia. Springer Berlin / Heidelberg. 52(2):208-212.
Publisher | Google Scholor - Samreen Riaz, Mehreen Raza, Saadia Shhazad Alam, Shahida Hasnain, M. Waheed Akhtar. (2009). Obesity as Risk Factor and Study of Obesity Related Proteins in Diabetes Mellitus. African Journal of Biotechnology. 8(5):737-744.
Publisher | Google Scholor - Nawaz, K., Riaz, S., Hasnain, S. (2009). Screening of Anti Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteriocin Producing Bacteria. African Journal of Biotechnology. 8(3):365-368.
Publisher | Google Scholor - Rabbani, N., Shahzad Alam, S., Riaz, S., Larkin, J.R., Akhtar, M.W., et al. (2009) High Dose Thiamine Therapy for Patients with Type 2 Diabetes and Microalbuminuria: A Pilot Randomised, Double-Blind, Placebo-Controlled Study. Diabetologia, 52(2):208-212.
Publisher | Google Scholor - Harman, C. (2009). Could Vitamin 'B' the Answer? Nature Reviews Endocrinology, 5(5):236-236.
Publisher | Google Scholor - Harman, C. (2009). Could Vitamin 'B' the Answer? Nature Reviews Nephrology. 5(4):182.
Publisher | Google Scholor - Riaz, S. (2009). Review of Diabetes Mellitus. Academic Journals, 4(5):367-373.
Publisher | Google Scholor - Samreen Riaz, Saadia Shahzad Alam, M. Waheed Akhtar. (2010). Proteomic Identification of Human Serum Biomarkers in Diabetes Mellitus Type-2. Journal of Pharmaceutical and Biomedical Analysis. 51(5):1103-1107.
Publisher | Google Scholor - Samreen Riaz, Ansa Butt. (2010). Study of Protein Profiling of Human Urine in Diabetic Hypertensive Nephropathy Versus Normal Healthy Controls. Diabetes Technology and Therapeutics. 12(5):379-386.
Publisher | Google Scholor - Samreen Riaz, Saadia Shahzad Alam, Surjit Kaila Srai, Vernon Skinner, Aasma Riaz et al. (2010). Proteomic Identification of Human Urine Biomarkers in Diabetes Mellitus Type-2. Journal of Diabetes Technology and Therapeutics. 12(12):979-988.
Publisher | Google Scholor - Samreen Riaz, Vernon Skinner, Surjit Kaila Srai. (2011). Effect of High Dose Thiamine on Levels of Human Urine Protein Biomarkers in Diabetes Mellitus Type 2. Journal of Pharmaceutical and Biomedical Analysis. 54(4):817-825.
Publisher | Google Scholor - Samreen Riaz, Vernon Skinner, Surjit Kaila Srai. (2011). Corrigendum to “Effect of High Dose Thiamine on The Levels of Urinary Protein Biomarkers in Diabetes Mellitus Type 2”, Journal of Pharmaceutical and Biomedical Analysis. 56(1):139.
Publisher | Google Scholor - Saadia Shahzad Alam, Samreen Riaz, M. Waheed Akhtar. (2011). Effect of High Dose Thiamine Therapy on Activity and Molecular Aspects of Transketolase in Type 2 Diabetic Patients. African Journal of Biotechnology. 10(75):17305-17316.
Publisher | Google Scholor - Saadia Shahzad Alam, Samreen Riaz, M. Waheed Akhtar. (2012). Effect of High Dose Thiamine Therapy on Risk Factors in Type 2 Diabetics. Journal of Diabetes and Metabolism, 3:10.
Publisher | Google Scholor - Saadia Shahzad Alam, Samreen Riaz, M. Waheed Akhtar. (2011). Effect of High Dose Thiamine Therapy on Induction and Activities of Pyruvate Dehydrogenase and Α-Ketoglutarate Dehydrogenase in Type 1 Diabetic Patients. British Journal of Medicine & Medical Research. 12(10):1-12.
Publisher | Google Scholor - Saadia Shahzad Alam, Samreen Riaz, M. Waheed Akhtar. (2013). Effect of High Dose Thiamine Therapy on Activity and Molecular Aspects of Transketolase in Type 1 Diabetic Patients. African Journal of Biotechnology. 12(75):17305-17316.
Publisher | Google Scholor - Saadia Shahzad Alam, Samreen Riaz, M. Waheed Akhtar. (2013). Effect of High Dose Thiamine Therapy on Induction and Activities of Pyruvate Dehydrogenase and Α-Ketoglutarate Dehydrogenase in Type 2 Diabetic Patients. Diabetes Technology & Therapeutics. 12(12):979-988.
Publisher | Google Scholor - Saadia Shahzad Alam, Samreen Riaz, M. Waheed Akhtar. (2013) Effect of High Dose Thiamine Therapy on Induction and Activities of Pyruvate Dehydrogenase and Α-Ketoglutarate Dehydrogenase in Type 1 Diabetic Patients. Diabetes Educator. 12(1):1-15.
Publisher | Google Scholor - Samreen Riaz, Sadia Rana. (2014). Analysis of Uropathogens Among Type II Diabetic Patients in Pakistani Population. Diabetes And Metabolism, 2(2):31-41.
Publisher | Google Scholor - Samreen Riaz. (2014). Obesity As a Risk Factor for Diabetes Mellitus in The Local Population of Pakistan. Universal Journal of Clinical Medicine. 2(3):58-64.
Publisher | Google Scholor - Riaz S. (2014). Evaluation and Analysis of Human Folate Levels in Pakistani Diabetic Population. International Journal of Scientific & Engineering Research, 5(12):1572-1576.
Publisher | Google Scholor - Riaz S. (2015), Study of Protein Biomarkers of Diabetes Mellitus Type 2 and Therapy with Vitamin B1. Journal of Diabetes Research. 1-10.
Publisher | Google Scholor - Saadia Shahzad Alam, Samreen Riaz (2016). Induction and Activities of Pyruvate Dehydrogenase And Α-Ketoglutarate Dehydrogenase in Type 2 Diabetic Patients and Therapy with Vitamin B1. International Journal of Advances in Medicine and Medical Research. 12(10)1-10.
Publisher | Google Scholor - Mursleen, M. T., Riaz, S. (2017). Implication of Homocysteine in Diabetes and Impact of Folate and Vitamin B12 in Diabetic Population. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11:S141-S146.
Publisher | Google Scholor - Riaz S. (2018). Therapeutic Implication of Folate-Homocysteine Interaction in The Local Diabetic Pakistani Population. Annals of Vascular Medicine Research. 5(1):1085-1089.
Publisher | Google Scholor - Afifa, Samreen Riaz. (2018). Analysis Of Pyridoxine in The Male Diabetic Population of Lahore and Sheikhupura. Annals of Diabetes Metabolic Disorders & Control. 2(1):118.
Publisher | Google Scholor - Riaz S., Tariq M. (2018). Linkage of Micro Albuminuria and Serum Albumin Levels in The Diabetic Patients Punjab University Premises. Annals of Diabetes Metabolic Disorders & Control. 2(1):117.
Publisher | Google Scholor - Riaz S., Tariq M., Aslam S. Association of Serum Protein Levels in The Diabetic Patients with Risk of Cardiovascular Disease and Nephropathy in Pakistani Population. Diabetes And Metabolism Journal. 4(1):11-15.
Publisher | Google Scholor - Afifa, Samreen Riaz. (2018). Analysis of Pyridoxine in The Male Diabetic Population of Lahore and Sheikhupura. Annals of Diabetes Metabolic Disorders & Control. 2(1):118.
Publisher | Google Scholor - Haseeba Yousaf, Samreen Riaz. (2018). Biomolecular Evaluation of Cobalamin (Vitamin B12) In the Diabetic Population of Lahore and Sheikhupura. Annals of Diabetes Metabolic Disorders & Control. 2(1):119.
Publisher | Google Scholor - Samreen Riaz, Shagufta Naz, Umera Kousar, Zil E Huma Malik, Rasheeda Bashir. (2018). Major Complication Associated with Diabetes Mellitus Type II in Punjab and Khyber Paktunkhwa Population. Diabetes and Metabolism, 9:809.
Publisher | Google Scholor - Javaria Yasin, Samreen Raiz. (2019). Evolutionary History and Molecular Epidemiology of HIV Pol Gene in Pakistan. Pakistan Journal of Medical Sciences. 15(1):1-10.
Publisher | Google Scholor - Samreen Riaz, Amina Mehboob. (2020). Olive Oil Tends to Lowers Cholesterol Level in Patients Suffering from Diabetes. Science Alert. International Journal of Biological Sciences. 1-10.
Publisher | Google Scholor - Nusair Malik, Arwa Faisal, Snobia Munir, Samreen Riaz. (2020). Clinical and Microbiological Profile of Urinary Tract Infection in Male Diabetic Patients. Journal of Microbiology and Experimentation. 8(1):30-34.
Publisher | Google Scholor - Farah Qudsia, Hafiza Amina Matti, Samreen Riaz. (2020). Pleiotropic Effect of Folate-Cobalamin Combinational Therapy on Diabetes Mellitus. Annals of Nutrition Disorders and Therapy. 7(1):1061.
Publisher | Google Scholor - Snobia Munir, Samreen Riaz. (2020). Type 2 Diabetes and Cancer. Annals of Clinical Endocrinology and Metabolism. 4:1-6.
Publisher | Google Scholor - Snobia Munir, Samreen Riaz. (2020). Molecular Association of Diabetes Mellitus with Different Types of Cancer from Population of Lahore. Annals Of Diabetes, Metabolic Disorders and Control. 3(1):126.
Publisher | Google Scholor - Hafiza Amina Matti, Samreen Riaz. (2022). Molecular Association of Cancer and Diabetes Mellitus with Combinational Therapy. International European Extended Enablement-In Science, Engineering & Management, 8(4).
Publisher | Google Scholor - Hafiza Amina Matti, Samreen Riaz. (2022). Evaluation of Environmental Influence of Arsenic Compounds on Patients Suffering from Type 2 Diabetes. International Journal of Scientific & Engineering Research.
Publisher | Google Scholor - Samreen Riaz, Shagufta Naz, Umera Kousar, Zil E Huma Malik, Rasheeda Bashir. (2020). The Association Between VEGF Rs699947 Polymorphism and Their Serum Level in Patients with Diabetic Foot Ulcer in Pakistani Population.
Publisher | Google Scholor - Samreen Riaz, Abdullah Mohsin, (2020). Role of Phytochemicals Derived from Plants Biodiversity and Its Impact in Treating COVID-19. Journal of Bioscience & Biomedical Engineering. 1(3)1-8.
Publisher | Google Scholor - Nusair Malik, M. S., Zubair, M., Riaz, S. (2020). Therapeutic Interventions of EVOO As Neutraceutical Agent to Lower Lipid Profile in The Diabetes Mellitus Type 2. Journal of Bioscience & Biongineering, 1(3):1-8.
Publisher | Google Scholor - Munir S, Riaz S, Arshad T, Riaz A. (2020). Risk Factors Associated to Patients with Type 2Diabetes In Lahore District. Annals of Clinical Endocrinology and Metabolism. 4:11-19.
Publisher | Google Scholor - Samreen Riaz. (2020). Molecular Association of Coronavirus with Diabetes Mellitus Type 2 In Pakistan Journal of Diabetes Research. 2(4):1-11.
Publisher | Google Scholor - Areeba Saeed, Sohaib Imtiaz, Samreen Riaz. (2020). Study of Urinary Tract Infection in Female Patients Suffering from Cancer. Journal of Cancer Research Reviews & Reports. 2(2):1-15.
Publisher | Google Scholor - Sohaib Imtiaz, Samreen Riaz. (2020). Antimicrobial Susceptibility Profile of Bacteria Isolated from Male Cancer Patients. International Journal of Clinical Studies & Medical Case Reports. 6(3):1-6.
Publisher | Google Scholor - Riaz, S., ul Arsalan, S., Ali, R., Riaz, A. (2020). Statistical Analysis to Identify the Effect of Risk Factors on Diabetic Patients from the Sheikh Zayed Hospital Lahore. Current Trends on Biostatistics and Biometrics, 3(3):368-382.
Publisher | Google Scholor - Iqbal, R., Aslam, S., Liaqat, I., Zafar, A., Aftab, K., & Riaz, S. (2021). Polymorphisms in CDKN2B-AS1 gene Confer a Risk for Myocardial Infarction in Pakistani Population. Bioscience Reports. BSR, 2003.
Publisher | Google Scholor - Shokat, S., Iqbal, R., Yaqub, A., Shahid, F., Riaz, S. (2021). Analysis of Environmental Pollutants as Diabetogenic Agent in The Patient Suffering from Diabetes Mellitus. Diabetes & Obesity International Journal, 6(1).
Publisher | Google Scholor